IDEXX Laboratories, Inc. (IDXX)
|Net Income (ttm)||674.21M|
|Trading Day||July 29|
|Day's Range||690.61 - 705.51|
|52-Week Range||347.54 - 705.51|
IDEXX Laboratories (IDXX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
IDEXX's (IDXX) fiscal second-quarter top line is expected to have benefited from strength in CAG and LPD businesses.
Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
They're not the growth stocks you're probably used to being huge winners.
How Millennials And Gen Z Are Bringing Animal Health Stocks To New Highs
A year of pandemic lockdowns yielded a year of lavish attention for pets. Animal health stocks like Zoetis and Idexx Laboratories reflected that rise in affection.
Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Among the 32 stocks Goldman Sachs Group Inc. ( GS , Financial) finds attractive, six are in health care, including the highly diversified Mettler-Toledo International Inc. ( MTD , Financial), a name tha...
Strong sales at the CAG and LPD arms are driving the top line for IDEXX Laboratories (IDXX).
The veterinary products company gained after an acquisition.
WESTBROOK, Maine, June 30, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has sche...
The stock price of IDEXX Laboratories, an animal healthcare company, has seen a rise of 12% in the last twenty-one trading days, while it is up a large 90% over the last one year. This rise can be attri...
Stocks like PetIQ (PETQ), IDEXX Laboratories (IDXX), Phibro Animal Health (PAHC) and Zoetis (ZTS) offering animal health products and services make great picks for long term.
Is (IDXX) Outperforming Other Medical Stocks This Year?
Investors are optimistic about IDEXX (IDXX) on strong growth in CAG business and bullish 2021 outlook.
Idexx Laboratories (IDXX) closed the most recent trading day at $560.35, moving +0.36% from the previous trading session.
The latest acquisition adds to IDEXX's (IDXX) cloud-based practice information management system (PIMS) segment.
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider IDEXX (IDXX).
Global leader in veterinary diagnostics and software enhances its practice management portfolio with acquisition of leading cloud-based solution WESTBROOK, Maine, June 2, 2021 /PRNewswire/ -- IDEXX Labo...
Idexx Labs reported another strong quarter and provided more details on its new product line.
Discovering new insights into Covid-19, particularly 'long Covid', InMode and Idexx peer Bruker continues to test new buy point. The post InMode, Idexx Peer Bruker Tests Buy Zone With New Insights Into ...
WESTBROOK, Maine, May 26, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will parti...
Stocks Dip After Recent Gains; Lam Research, United Airlines, Idexx Labs In Focus
Stocks Dip after recent gains; Lam Research, United Airlines, Idexx Labs in focus. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing ...
After a 147% gain from its March 2020 lows, the BOUT ETF, featuring growth stocks like Nvidia and GS stock, tests turbulence. The post Breakout Watch: Nvidia, Idexx, GS Stock Among Growth Stocks Testing...
IDEXX (IDXX) registers strong contribution from its CAG business in the first quarter despite pandemic-induced challenges.
Idexx (IDXX) delivered earnings and revenue surprises of 36.63% and 5.87%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
WESTBROOK, Maine, May 4, 2021 /PRNewswire/ -- Achieves reported revenue growth of 24% and organic growth of 21%, driven by CAG Diagnostics recurring revenue growth of 27% as reported and 23% organic Del...
In the latest trading session, Idexx Laboratories (IDXX) closed at $548.99, marking a -0.66% move from the previous day.
Joining fellow medical sector stock Veeva on this list of top long-term growth stocks, Idexx has investors wagging their tails ahead of Q1 earnings. The post After 240% Run, Long-Term Leader Sniffs Out ...
IDEXX (IDXX) first-quarter top line is expected to have benefited from strength in CAG and LPD businesses.
Market Rally, Leaders Suffer Further Damage: United Airlines, Freeport McMoran, Idexx Labs In Focus
Market rally suffers further damage, leaders hard hit: United Airlines, Freeport McMoran, Idexx Labs in focus. Investor's Business Daily has been helping people invest smarter results by providing exclu...
The potential is staggering.
WESTBROOK, Maine, April 8, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has sched...
Idexx Laboratories (IDXX) closed at $487.66 in the latest trading session, marking a -0.76% move from the prior day.
IDEXX's (IDXX) Global Reference Lab revenues are growing organically in the United States and in international markets.
One of the best-performing investment funds of the last decade is not a secretive Wall Street hedge fund. It's not even a private office or exchange-traded fund.
Investors in IDEXX stock are betting on continued growth in the company's core business and continued interest by investors in this segment. The post Idexx Laboratories Is a Great High-Margin Growth Pla...
Investors are optimistic about IDEXX (IDXX) backed by robust CAG and LPD revenues growth and strong global performance boosting the top line.
IDEXX Laboratories (IDXX) has been struggling lately, but the selling pressure may be coming to an end soon
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems a... [Read more...]
Diagnostics & Research
|IPO Date |
Jun 21, 1991
Jonathan Jay Mazelsky
|Stock Exchange |
|Ticker Symbol |
In 2020, IDXX's revenue was $2.71 billion, an increase of 12.45% compared to the previous year's $2.41 billion. Earnings were $581.78 million, an increase of 36.02%.
According to 11 analysts, the average rating for IDXX stock is "Buy." The 12-month stock price forecast is 585.40, which is a decrease of -16.87% from the latest price.